229 related articles for article (PubMed ID: 12855811)
21. Platinum-induced space-group transformation in crystals of the platelet glycoprotein Ib alpha N-terminal domain.
Varughese KI; Ruggeri ZM; Celikel R
Acta Crystallogr D Biol Crystallogr; 2004 Mar; 60(Pt 3):405-11. PubMed ID: 14993663
[TBL] [Abstract][Full Text] [Related]
22. Anti-beta2-glycoprotein I antibodies in complex with beta2-glycoprotein I can activate platelets in a dysregulated manner via glycoprotein Ib-IX-V.
Shi T; Giannakopoulos B; Yan X; Yu P; Berndt MC; Andrews RK; Rivera J; Iverson GM; Cockerill KA; Linnik MD; Krilis SA
Arthritis Rheum; 2006 Aug; 54(8):2558-67. PubMed ID: 16868978
[TBL] [Abstract][Full Text] [Related]
23. Antithrombotic effect of a protein-type I class snake venom metalloproteinase, kistomin, is mediated by affecting glycoprotein Ib-von Willebrand factor interaction.
Hsu CC; Wu WB; Chang YH; Kuo HL; Huang TF
Mol Pharmacol; 2007 Oct; 72(4):984-92. PubMed ID: 17609416
[TBL] [Abstract][Full Text] [Related]
24. Binding of alpha-thrombin to surface-anchored platelet glycoprotein Ib(alpha) sulfotyrosines through a two-site mechanism involving exosite I.
Zarpellon A; Celikel R; Roberts JR; McClintock RA; Mendolicchio GL; Moore KL; Jing H; Varughese KI; Ruggeri ZM
Proc Natl Acad Sci U S A; 2011 May; 108(21):8628-33. PubMed ID: 21555542
[TBL] [Abstract][Full Text] [Related]
25. The GPIbalpha-thrombin interaction: far from crystal clear.
Vanhoorelbeke K; Ulrichts H; Romijn RA; Huizinga EG; Deckmyn H
Trends Mol Med; 2004 Jan; 10(1):33-9. PubMed ID: 14720584
[No Abstract] [Full Text] [Related]
26. The interaction of thrombin with blood platelets.
Lundblad RL; White GC
Platelets; 2005 Nov; 16(7):373-85. PubMed ID: 16236598
[TBL] [Abstract][Full Text] [Related]
27. Dual inhibition of HY023016 based on binding properties of platelet membrane receptor subunit glycoprotein Ibα and thrombin exosites.
Chen QF; Cui S; Shen HL; Chen X; Li YZ; Wu Q; Xu YG; Gong GQ
Eur J Pharmacol; 2018 Mar; 822():51-58. PubMed ID: 29355554
[TBL] [Abstract][Full Text] [Related]
28. Inhibition of von Willebrand factor-GPIb/IX/V interactions as a strategy to prevent arterial thrombosis.
Bonnefoy A; Vermylen J; Hoylaerts MF
Expert Rev Cardiovasc Ther; 2003 Jul; 1(2):257-69. PubMed ID: 15030285
[TBL] [Abstract][Full Text] [Related]
29. Crystal structure of a platelet-agglutinating factor isolated from the venom of Taiwan habu (Trimeresurus mucrosquamatus).
Huang KF; Ko TP; Hung CC; Chu J; Wang AH; Chiou SH
Biochem J; 2004 Mar; 378(Pt 2):399-407. PubMed ID: 14613481
[TBL] [Abstract][Full Text] [Related]
30. Molecular basis of the initial platelet adhesion in arterial thrombosis: molecular dynamics simulations.
Li J; Zhang L; Sun Y
J Mol Graph Model; 2012 Jul; 37():49-58. PubMed ID: 22622010
[TBL] [Abstract][Full Text] [Related]
31. The Asp(272)-Glu(282) region of platelet glycoprotein Ibalpha interacts with the heparin-binding site of alpha-thrombin and protects the enzyme from the heparin-catalyzed inhibition by antithrombin III.
De Cristofaro R; De Candia E; Rutella S; Weitz JI
J Biol Chem; 2000 Feb; 275(6):3887-95. PubMed ID: 10660541
[TBL] [Abstract][Full Text] [Related]
32. gammaA/gamma' fibrinogen inhibits thrombin-induced platelet aggregation.
Lovely RS; Rein CM; White TC; Jouihan SA; Boshkov LK; Bakke AC; McCarty OJ; Farrell DH
Thromb Haemost; 2008 Nov; 100(5):837-46. PubMed ID: 18989528
[TBL] [Abstract][Full Text] [Related]
33. Thrombin binding to GPIbalpha induces platelet aggregation and fibrin clot retraction supported by resting alphaIIbbeta3 interaction with polymerized fibrin.
Dubois C; Steiner B; Kieffer N; Reigner SC
Thromb Haemost; 2003 May; 89(5):853-65. PubMed ID: 12719784
[TBL] [Abstract][Full Text] [Related]
34. Thrombocytopathy leading to impaired in vivo haemostasis and thrombosis in platelet type von Willebrand disease.
Kaur H; Corscadden K; Ware J; Othman M
Thromb Haemost; 2017 Feb; 117(3):543-555. PubMed ID: 28004055
[TBL] [Abstract][Full Text] [Related]
35. Platelet adhesion to dimeric beta-glycoprotein I under conditions of flow is mediated by at least two receptors: glycoprotein Ibalpha and apolipoprotein E receptor 2'.
Pennings MT; Derksen RH; van Lummel M; Adelmeijer J; VanHoorelbeke K; Urbanus RT; Lisman T; de Groot PG
J Thromb Haemost; 2007 Feb; 5(2):369-77. PubMed ID: 17096706
[TBL] [Abstract][Full Text] [Related]
36. Glycoprotein Ibalpha inhibition and ADP receptor antagonists, but not aspirin, reduce platelet thrombus formation in flowing blood exposed to atherosclerotic plaques.
Penz SM; Reininger AJ; Toth O; Deckmyn H; Brandl R; Siess W
Thromb Haemost; 2007 Mar; 97(3):435-43. PubMed ID: 17334511
[TBL] [Abstract][Full Text] [Related]
37. Structure of the platelet glycoprotein Ib receptor in complex with a novel antithrombotic agent.
Wang J; Gao Y; Chen L; Guo Y; Hu S; Cheng L; Xiao W; Ke J; Zhu Z; Niu L
Blood; 2021 Feb; 137(6):844-847. PubMed ID: 33181828
[TBL] [Abstract][Full Text] [Related]
38. Thrombin mutant W215A/E217A acts as a platelet GPIb antagonist.
Berny MA; White TC; Tucker EI; Bush-Pelc LA; Di Cera E; Gruber A; McCarty OJ
Arterioscler Thromb Vasc Biol; 2008 Feb; 28(2):329-34. PubMed ID: 17962622
[TBL] [Abstract][Full Text] [Related]
39. Unravelling the mechanism and significance of thrombin binding to platelet glycoprotein Ib.
Ruggeri ZM; Zarpellon A; Roberts JR; Mc Clintock RA; Jing H; Mendolicchio GL
Thromb Haemost; 2010 Nov; 104(5):894-902. PubMed ID: 20941453
[TBL] [Abstract][Full Text] [Related]
40. Dimerization of glycoprotein Ibα is not sufficient to induce platelet clearance.
Liang X; Syed AK; Russell SR; Ware J; Li R
J Thromb Haemost; 2016 Feb; 14(2):381-6. PubMed ID: 26662889
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
